Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2020 Financial Results
Neurocrine Biosciences (Nasdaq: NBIX) will report its third-quarter financial results after market close on November 9, 2020. A conference call will follow at 1:30 p.m. PT, 4:30 p.m. ET, to discuss the results and provide updates. Participants can access the call at 877-830-2596 (US) or 785-424-1744 (International) with conference ID: NBIX. The event will be available for replay on the company's website for approximately one month. Neurocrine specializes in developing treatments for neurological and psychiatric disorders.
- None.
- None.
SAN DIEGO, Oct. 6, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will report third quarter financial results after the Nasdaq market closes on Monday, November 9, 2020. Neurocrine will then host a conference call and webcast to discuss its financial results and provide a company update that day at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Participants can access the live conference call by dialing 877-830-2596 (US) or 785-424-1744 (International) using the conference ID: NBIX. The webcast can also be accessed on Neurocrine's website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis* and uterine fibroids*, with three pivotal and five mid-stage clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)
View original content to download multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-third-quarter-2020-financial-results-301147076.html
SOURCE Neurocrine Biosciences, Inc.
FAQ
When will Neurocrine Biosciences report its third-quarter financial results?
What time is the conference call for Neurocrine's Q3 financial results?
How can I access the Neurocrine Biosciences conference call?
Will the Neurocrine Biosciences conference call be available for replay?
